The main causes which are responsible for secondary chemoresistance of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003
The development of mutant P53 characterized by lung cancers contributes to their primary and acquired multi-drug resistance to chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 457s Year: 2005
The main causes which lead to immediate and belated failure in tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 141s Year: 2005
Anthracosis of lung: evaluation of potential underlying causes Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
What are the main mechanisms of oncogenic addiction? Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019
Modified sensitivity of alveolar cells to TRAIL-mediated apoptosis: a mechanism involved in emphysema pathogenesis with a potential impact on cancer therapy research Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Does acute phase protein alpha1-antitrypsin modulate apoptosis-autophagy crosstalk resulting in resistance of NSCLC cells to cancer drugs? Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung Source: Eur Respir J, 58 (3) 1901789; 10.1183/13993003.01789-2019 Year: 2021
The effect of new drug-resistance antisense gene on multidrug resistance mechanism of drug-resistant human small cell lung cancer cells Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007
Mechanisms leading to the bronchorelaxant synergy of ICS/LABA/LAMA combination Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019
TRAP1 downregulation could overcome gefitinib resistance in NSCLC via EMT reversal Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018
Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007
Epigenetic deregulated translation control of C/EBP-alpha leads to increased mesothelioma cell proliferation Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011
PTEN deficiency in alveolar type 2 cells accelerates cellular senescence, disrupts epithelial–mesenchymal and mitochondrial homeostasis, and induces age-related emphysema Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology Year: 2019
Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage Source: Eur Respir J 2003; 22: Suppl. 45, 458s Year: 2003
Molecular mechanisms are involved in ethanol mediated lung endothelial barrier dysfunction Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
A complex case of respiratory failure secondary to an unusual lung pathological finding in a patient with COVID-19 Source: Virtual Congress 2021 – CCC Respiratory critical care Year: 2021
Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006
Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011